Indeed, hypoalbuminemia has been reported as a prognostic factor for immune-checkpoint therapy (ICT) in lung cancer [30], and the Gustave Roussy Immune Score, which is used as a prognostic indicator for ICT, includes low albumin as one of its components [31]. This evidence concerns the gene ALB and Hypoalbuminemia.